LBPO.IM02 · 免疫学 · Late-Breaking
Late-Breaking Research: Immunology 2
-
- LB137 LB137 E-选择素配体工程化克服转运障碍以增强过继性T细胞和BiTE治疗 E-selectin ligand engineering overcomes trafficking barriers to potentiate adoptive T-cell and BiTE therapies Yingqin Hou, Peng Wu
- LB138 LB138 EGFR靶向KIR-CAR T中基于自然杀伤细胞的信号传导克服了基于CD3的CAR T功能缺陷，在体内清除耐药性胶质母细胞瘤 Natural killer cell-based signaling in EGFR-targeted KIR-CAR T overcomes CD3-based CAR T functional deficits to eliminate resistant glioblastomas in vivo Jun Xu, Radhika Thokala, Yibo Yin, Chong Xu, Alina C. Boesteanu, Alexandria P. Cogdill, Zev A. Binder, Logan Zhang, Jiasi Vicky Zhang, Enxiu Wang, Carl H. June, Donald M. O'Rourke, Michael C. Milone, Laura A. Johnson
-
-
-
-
-
-
-
-
-
-
- LB150 LB150 衰老作为免疫耐受打破者：有丝分裂激酶TTK（Mps1）和AURKA的抑制剂通过cGAS-STING信号诱导促免疫原性衰老，为肿瘤微环境接受免疫治疗做准备 Senescence as an immune tolerance breaker: Inhibitors of mitotic kinases TTK (Mps1) and AURKA induce pro-immunogenic senescence that primes the tumor microenvironment for immunotherapy via cGAS-STING signaling Marina Capece, Evdokiya Reshetnikova, Yinchong Wang, Arjun Mittra, Anna E. Vilgelm
-
-
-
-
-
